RDNT
RadNet, Inc.
Key Financials
Operating Income
$62.0M
↓ 40.7%
Revenue
$2.0B
↑ 11.5%
Net Income
$-18652000
↓ 767.8%
Shareholders' Equity
$1.1B
↑ 20.8%
EPS (Diluted)
$-0.25
↓ 725.0%
Cash & Equivalents
$767.2M
↑ 3.7%
Total Assets
$3.8B
↑ 14.4%
Total Liabilities
$2.4B
↑ 11.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/14/2026 | View on SEC |
| 424B7 | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/10/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/18/2026 | View on SEC |
| 4 | 6/18/2026 | View on SEC |
| 144 | 6/18/2026 | View on SEC |
| 144 | 6/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RDNT |
| Company Name | RadNet, Inc. |
| CIK | 790526 |
| Sector | Services-Medical Laboratories |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 3104787808 |